Kinesins play important roles in the progression and development of cancer. Kinesin family member C1 (KIFC1), a minus end-directed motor protein, is a novel Kinesin involved in the clustering of excess centrosomes found in cancer cells.
Recent literature highlights the importance of germline genetic testing in prostate cancer (PCa) patients. Surprisingly, a literature review indicates that family history (FH) records are incomplete in the major published studies from prostate cancer patients.
Prostate cancer is currently the second leading cause of cancer deaths in Brazilian men. In 2020, sixty-five thousand new prostate cancer cases were expected in Brazil, and almost 30% of these patients are estimated to be from the northeast region.
Urothelial bladder cancer (UBC) is a common malignancy with considerable mortality worldwide. However, the treatment options of UBC are mainly chemotherapy and immunotherapy, as few targeted agents have demonstrated efficacy against UBC.
The Bacillus Calmette-Guerin (BCG) vaccine has long been used for the prevention of tuberculosis (TB) around the world. BCG is also used as an immunotherapy agent for the treatment of non-muscle invasive urinary bladder cancer.
Introduction African American (AA) race has been identified to have a higher incidence of chronic kidney disease (CKD) and worse renal cancer survival compared to Caucasian Americans (CA) irrespective of tumor size, pathological type, and surgical procedure.
To compare sites of metastasis for the laparoscopic (LRC) and open (ORC) approaches in a cohort of patients at a district general hospital. Morbidity and mortality for the two approaches are assessed using secondary outcomes of length of stay and complication rate.
Black men are approximately two times more likely to develop and die from advanced prostate cancer compared to white men. Despite these disparities, Black men comprise less than three percent of therapeutic clinical trials in advanced prostate cancer. Disparities in whom cancer clinical trials serve is a long-standing problem that is likely further widening the […]
Alicia Morgans: Hi, my name is Alicia Morgans, and I’m a GU Medical Oncologist and Associate Professor of Medicine at Northwestern University in Chicago in the United States. I’m so excited to have here with me today, a friend and colleague, Dr. Tia Higano, who is a GU Medical Oncologist, who needs no further introduction, out […]
– PCORI-Funded Initiative to Bring Together Patients, Doctors, and Other Key Stakeholders to Explore Use of Monitoring for Eligible Patients Versus Immediate San Francisco, CA (UroToday.com) — Researchers at the University of Maryland School of Medicine (UMSOM) have been awarded $100,000 in funding through the Eugene Washington PCORI Engagement Awards, an initiative of the Patient-Centered Outcomes Research Institute […]
